Repeated S-ketamine Infusions in Therapy Resistant Depression: A Case Series-Reference-Cited by-同舟云学术

Repeated S-ketamine Infusions in Therapy Resistant Depression: A Case Series

Published:2013-07-24 Issue:9 Volume:53 Page:996-998
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Segmiller Felix¹,Rüther Tobias¹,Linhardt Andrea¹,Padberg Frank¹,Berger Michael¹,Pogarell Oliver¹,Möller Hans-Jürgen¹,Kohler Christina²,Schüle Cornelius¹

Affiliation:

1. Department of Psychiatry and Psychotherapy; Ludwig Maximilian University; Munich Germany

2. Department of Psychiatry and Psychotherapy; BKH Augsburg; Augsburg Germany

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.122/fullpdf

Reference8 articles.

1. Antidepressant effects of ketamine in depressed patients;Berman;Biol Psychiatry.,2000

2. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression;Zarate;Arch Gen Psychiatry.,2006

3. Ketamine for depression: where do we go from here?;Aan Het Rot;Biol Psychiatry.,2012

4. Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases;Paul;World J Biol Psychiatry.,2009

5. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression;aan het Rot;Biol Psychiatry.,2010

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review;Pharmacology Biochemistry and Behavior;2024-09

2. Ketamin und Esketamin;Nervenheilkunde;2024-06

3. Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects;International Journal of Molecular Sciences;2022-12-08

4. Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression;CNS & Neurological Disorders - Drug Targets;2022-08

5. Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial;Frontiers in Psychiatry;2022-07-22